Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.47
+0.06 (1.11%)
Sep 17, 2025, 4:00 PM EDT - Market closed
Solid Biosciences Market Cap
Solid Biosciences has a market cap or net worth of $425.94 million as of September 18, 2025. Its market cap has increased by 23.59% in one year.
Market Cap
425.94M
Enterprise Value
180.88M
1-Year Change
23.59%
Ranking
Category
Stock Price
$5.47
Market Cap Chart
Since January 26, 2018, Solid Biosciences's market cap has decreased from $7.30B to $425.94M, a decrease of -94.17%. That is a compound annual growth rate of -31.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 425.94M | 166.52% |
| Dec 31, 2024 | 159.82M | 29.00% |
| Dec 29, 2023 | 123.89M | 17.92% |
| Dec 30, 2022 | 105.06M | -45.57% |
| Dec 31, 2021 | 193.02M | -61.33% |
| Dec 31, 2020 | 499.18M | 143.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |